Effects of psychotropic drugs on inflammation:Consequence or mediator of therapeutic effects in psychiatric treatment?
The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Rationale Current psychotropic medications have been shown to modulate immune activation. However, the effects of individual psychotropic agents on the immune system and how these might contribute to their efficacy remain largely unclear. Objective This paper aims to review previous literature on the effects of antidepressants and antipsychotics on the immune system, with a systematic review of in vitro findings, and discuss the relevance of these effects for the response to treatment and future drug development. Results Inflammatory markers have been associated with fluctuations in clinical status and with treatment response both in depression and psychosis. The in vitro literature on antidepressants shows that some antidepressants, such as clomipramine and fluoxetine, more consistently decrease pro-inflammatory cytokines (interleukin (IL)-6, interferon (IFN)-γ, tumour necrosis factor (TNF)-α), whilst others (mirtazapine and venlafaxine) tend to increase their levels. However, any overall conclusion is challenged by several inconsistent findings, which appear partly dependent on different methodological approaches used. The in vitro studies on antipsychotics are even less clear-cut showing pro- and anti-inflammatory activity for the same antipsychotic agent (haloperidol, clozapine, risperidone) across different studies. We also noted inconsistencies between in vivo and in vitro literature, which could partly be attributed to the interaction in vivo with various biological sy…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Different psychotropic medications may affect the inflammatory state via different mechanisms.[12,13]”
In the citing paper
“Psychotropic medicines may have an anti-inflammatory effect, signified by the fact that 1st episode mania group has a greater level of inflammation in comparison to bipolar mania.”
In the citing paper
“The in vitro literature on antidepressants suggest that some antidepressants, such as clomipramine and fluoxetine, decrease IL-6, IFN-γ, and TNF-α, whilst others like mirtazapine and venlafaxine tend to increase their levels (207).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [207]
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 2×
“Antipsychotics Miller et al. (2011) ↓ = = ↑ – – ↓ – = = ↑ = – ↓ =”
BackgroundThe pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Nanni, V., Uher, R., & Danese, A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020335 · Cited by 1,480
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C. M., & Mondelli, V (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.67 · Cited by 1,084 · cited 2×
“For example, psychosocial stress and childhood adversity, well-known precipitants of psychiatric disorders, have been recognised to stimulate the release of a variety of inflammatory markers (Hepgul et al. 2012; Di Nicola et al. 2013; Miller et al. 2009; Baumeister et al. 2015).”
BackgroundSelf-citationCRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Reactive nitrogen species in the chemical biology of inflammation
Dedon, P. C., & Tannenbaum, S. R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.017 · Cited by 681
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Cannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T. G. M., McEwen, S., Addington, J., Bearden, C. E., Cadenhead, K., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.023 · Cited by 599 · cited 1×
“reduction in regional cortical thickness) of patients with either psychosis or depression have emerged, opening up the possibility to use the inflammatory biomarkers as a clinical predictors (O’Brien et al. 2007; Cannon et al. 2014; Mondelli et al. 2015).”
BackgroundGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Neuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., Winter, C., Riva, M. A., Mortensen, P. B., Feldon, J., et al. (2013) · Science · doi:10.1126/science.1228261 · Cited by 459
Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.191 · Cited by 436
Zautra, A. J., Davis, M. C., Reich, J. W., Nicassario, P., Tennen, H., Finan, P., Kratz, A., Parrish, B., & Irwin, M. R. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.408 · Cited by 430
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · cited 1×
“More recently, it was reported that the levels of several cytokines, including IL-1RA, IL-6, IL-8 and IFN-γ, normalise in depressed patients after recovery, supporting the presence of increased inflammatory state during the acute phase of depression (Dahl et al. 2014).”
BackgroundInterleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388
The role of inflammatory cytokines as key modulators of neurogenesis
Borsini, A., Zunszain, P. A., Thuret, S., & Pariante, C. M. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.12.006 · Cited by 381 · cited 1×
“Several studies in foetal human and rodent hippocampal neural progenitor cells have reported decreased neurogenesis yet increased gliogenesis when exposed to IL1β or TNF-α (Johansson et al. 2008; Zunszain et al. 2012; Crampton et al. 2012; Chen et al. 2013a, b; Borsini et al. 2015).”
BackgroundCairns, K. E., Yap, M. B. H., Pilkington, P. D., & Jorm, A. F. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.006 · Cited by 363 · cited 1×
“2014), whilst exercise, calorie restriction or supplementation with omega-3 polyunsaturated fatty acids can decrease inflammation and improve mental well-being (Kiecolt-Glaser et al. 2011; Numao et al. 2012; MacDonald et al. 2014; Cairns et al. 2014).”
BackgroundMaes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
O’Brien, S. M., Scully, P., Fitzgerald, P., Scott, L. V., & Dinan, T. G. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.013 · Cited by 355
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Sommer, I. E., van Westrhenen, R., Begemann, M. J. H., de Witte, L. D., Leucht, S., & Kahn, R. S. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt139 · Cited by 342
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., & Glaser, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.229 · Cited by 340
Xia, Z., Depierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318
Rosenkranz, M. A., Davidson, R. J., MacCoon, D. G., Sheridan, J. F., Kalin, N. H., & Lutz, A. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.013 · Cited by 307
Mondelli, V., Cattaneo, A., Murri, M. B., Di Forti, M., Handley, R., Hepgul, N., Miorelli, A., Navari, S., Papadopoulos, A. S., Aitchison, K. J., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06745 · Cited by 303
Self-citationPro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290 · cited 2×
“Similarly, a meta-analysis on inflammatory changes in depression in clinical as well as community-based samples found elevations of IL-1β, IL-6 and CRP with a stronger effect in clinically depressed samples (Howren et al. 2009). Noteworthy, their study included samples comorbid for coronary artery disease or cancer. A…”
BackgroundResultCortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv028 · Cited by 286
Self-citationCytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
Cytokines in schizophrenia and the effects of antipsychotic drugs
Drzyzga, Ł., Obuchowicz, E., Marcinowska, A., & Herman, Z. S. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.02.002 · Cited by 242
André, C., Dinel, A.-L., Ferreira, G., Layé, S., & Castanon, N. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.012 · Cited by 241
Effects of Clozapine on Plasma Cytokine and Soluble Cytokine Receptor Levels
Pollmacher, T., Hinze-Selch, D., & Mullington, J. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00011 · Cited by 232
Schwieler, L., Larsson, M. K., Skogh, E., Kegel, M. E., Orhan, F., Abdelmoaty, S., Finn, A., Bhat, M., Samuelsson, M., Lundberg, K., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140126 · Cited by 226
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Tourjman, V., Kouassi, É., Koué, M.-È., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.011 · Cited by 224
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
Ganguli, R., Yang, Z., Shurin, G., Chengappa, K. N. R., Brar, J. S., Gubbi, A. V., & Rabin, B. S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90042-6 · Cited by 222
The role of environmental factors in modulating immune responses in early life
MacGillivray, D. M., & Kollmann, T. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00434 · Cited by 219
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000128 · Cited by 219
Serum and gene expression profile of cytokines in first-episode psychosis
Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.010 · Cited by 217
Self-citationInflammatory dietary pattern and risk of depression among women
Lucas, M., Chocano-Bedoya, P., Shulze, M. B., Mirzaei, F., O’Reilly, É. J., Okereke, O. I., Hu, F. B., Willett, W. C., & Ascherio, A. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.09.014 · Cited by 216
Dickerson, F., Stallings, C., Origoni, A., Boronow, J., & Yolken, R. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.022 · Cited by 205
Nitta, M., Kishimoto, T., Müller, N., Weiser, M., Davidson, M., Kane, J. M., & Correll, C. U. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt070 · Cited by 204
Yang, J.-J., Wang, N., Yang, C., Shi, J.-Y., Yu, H.-Y., & Hashimoto, K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.021 · Cited by 202
Barrientos, R. M., Sprunger, D. B., Campeau, S., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.009 · Cited by 192 · cited 1×
“For example, administration of IL-1β has been shown to down-regulate expression of brain-derived neurotrophic factor (BDNF) in the rat hippocampus (Barrientos et al. 2004); moreover, pro-inflammatory cytokines and BDNF can act on common intracellular pathways relevant to neuroplasticity, like the mitogen-activated pro…”
BackgroundStojanovic, A., Martorell, L., Montalvo, I., Ortega, L., Monseny, R., Vilella, E., & Labad, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.12.005 · Cited by 170
PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers
Manji, H. K., & Chen, G. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001018 · Cited by 165
Lengacher, C. A., Kip, K. E., Barta, M., Post-White, J., Jacobsen, P. B., Groer, M., Lehman, B., Moscoso, M. S., Kadel, R., Le, N., et al. (2012) · Journal of Holistic Nursing · doi:10.1177/0898010111435949 · Cited by 163
Borges, S., Gayer-Anderson, C., & Mondelli, V. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.025 · Cited by 153 · cited 1×
“2007), which can also affect CNS function and has been implicated in several psychiatric conditions, including depression and psychosis (Borges et al. 2013; Baumeister et al. 2014a).”
BackgroundSelf-citationThe role of inflammatory cytokines in suicidal behavior: A systematic review
Serafini, G., Pompili, M., Elena Seretti, M., Stefani, H., Palermo, M., Coryell, W., & Girardi, P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.002 · Cited by 151
Johansson, S., Price, J., & Modo, M. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0116 · Cited by 148
Bettini, M., & Ziegler, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5024 · Cited by 146
Song, C., Lin, A., Kenis, G., Bosmans, E., & Maes, M. H. J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00116-4 · Cited by 144
Baumeister, D., Russell, A., Pariante, C. M., & Mondelli, V. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0887-z · Cited by 142
Self-citationDiamond, M., Kelly, J. P., & Connor, T. J. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.011 · Cited by 141
Martinez, J. M., Garakani, A., Yehuda, R., & Gorman, J. M. (2012) · Depression and Anxiety · doi:10.1002/da.20876 · Cited by 131
Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder
Dickerson, F., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., & Yolken, R. H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.039 · Cited by 129
Stimulatory effect of antidepressants on the production of IL-6
Kubera, M., Kenis, G., Bosmans, E., Kajta, M., Basta-Kaim, A., Scharpe, S., Budziszewska, B., & Maes, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2003.11.006 · Cited by 126 · cited 1×
“We identified 17 eligible studies using antidepressants (Table 1; Xia et al. 1996; Maes et al. 1999; Lin et al. 2000; Kubera et al. 2001; Kubera et al. 2002; Rudolf et al. 2002; Szuster-Ciesielska et al. 2003; Kubera et al. 2004; Maes et al. 2005; Diamond et al. 2006; Carvalho et al. 2008; Carvalho et al. 2010; Himmer…”
MethodImpact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
Hepgul, N., Pariante, C. M., Dipasquale, S., DiForti, M., Taylor, H., Marques, T. R., Morgan, C., Dazzan, P., Murray, R. M., & Mondelli, V. (2012) · Psychological Medicine · doi:10.1017/s0033291711002947 · Cited by 112
Self-citationIda, T., Hara, M., Nakamura, Y., Kozaki, S., Tsunoda, S., & Ihara, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.047 · Cited by 107
The interface of stress and the HPA axis in behavioural phenotypes of mental illness
Baumeister, D., Lightman, S. L., & Pariante, C. M. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_304 · Cited by 104
Impact of antipsychotics on cytokine production in-vitro
Himmerich, H., Schönherr, J., Fulda, S., Sheldrick, A. J., Bauer, K., & Sack, U. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.04.009 · Cited by 104
Song, X., Fan, X., Li, X., Zhang, W., Gao, J., Zhao, J., Harrington, A., Ziedonis, D. M., & Lv, L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3382-4 · Cited by 103
Short and long term immunosuppressive effects of clozapine and haloperidol
Leykin, I., Mayer, R., & Shinitzky, M. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00037-4 · Cited by 101
Tsai, S., Yang, Y.-Y., Kuo, C.-J., Chen, C., & Leu, S.-J. C. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00252-4 · Cited by 96
Grinberg, Y. Y., Dibbern, M. E., Levasseur, V. A., & Kraig, R. P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12267 · Cited by 94
Chen, E., Xu, D., Lan, X., Jia, B., Sun, L., Zheng, J., & Peng, H. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990076 · Cited by 84
Carvalho, L. A., Juruena, M. F., Papadopoulos, A. S., Poon, L., Kerwin, R., Cleare, A. J., & Pariante, C. M. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.44 · Cited by 75
Crampton, S. J., Collins, L. M., Toulouse, A., Nolan, Y. M., & O’Keeffe, G. W. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07634.x · Cited by 74
Hinze‐Selch, D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00006-2 · Cited by 74
Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine
Klemettilä, J.-P., Kampman, O., Seppälä, N., Viikki, M., Hämäläinen, M., Moilanen, E., & Leinonen, E. V. J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.049 · Cited by 70
First-Episode Psychosis: An Inflammatory State?
Zajkowska, Z., & Mondelli, V. (2014) · Neuroimmunomodulation · doi:10.1159/000356536 · Cited by 68
Self-citationThe negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway
Maes, M. H. J., Kenis, G., Kubera, M., de Baets, M., Steinbusch, H. W. M., & Bosmans, E. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.11.008 · Cited by 68
Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines
Moots, R. J., Al-Saffar, Z., Hutchinson, D. G., Golding, S., Young, S., Bacon, P. A., & McLaughlin, P. J. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.9.585 · Cited by 67
In vitro immunoregulatory effects of antidepressants in healthy volunteers.
Szuster‐Ciesielska, A., Tustanowska-Stachura, A., Słotwińska, M., Marmurowska-Michałowska, H., & Kandefer‐Szerszeń, M. (2003) · PubMed · Cited by 66
The in vitro immunosuppressive effects of moclobemide in healthy volunteers
Lin, A., Song, C., Kenis, G., Bosmans, E., Jongh, R. F. D., Scharpé, S., & Maes, M. H. J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00076-2 · Cited by 62
Ayorech, Z., Tracy, D. K., Baumeister, D., & Giaroli, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.015 · Cited by 62
Self-citationChen, M., Tsai, T., Lin, Y.-Y., Tsai, Y.-M., Wang, L., Lee, M.-C., & Tsai, F. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.06.011 · Cited by 59
Carvalho, L. A., Garner, B. A., Dew, T., Fazakerley, H., & Pariante, C. M. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.006 · Cited by 56
MacDonald, L., Hazi, A., Paolini, A. G., & Kent, S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.01.005 · Cited by 54
Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine
O’Connell, K. E., Thakore, J. H., & Dev, K. K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.020 · Cited by 52
Mondelli, V., & Howes, O. D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3383-3 · Cited by 51
Self-citationRegulation of macrophage immune responses by antipsychotic drugs
Chen, M.-L., Wu, S., Tsai, T.-C., Wang, L.-K., & Tsai, F.-M. (2013) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2013.828744 · Cited by 50
Viviani, B., Boraso, M., Valero, M., Gardoni, F., Marco, E. M., Llorente, R., Corsini, E., Galli, C. L., Luca, M. D., Marinovich, M., et al. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.09.008 · Cited by 48
Krause, D., Riedel, M. J., Müller, N., Weidinger, E., Schwarz, M., & Myint, A.-M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0112-6 · Cited by 45
Fornaro, M., Martino, Battaglia, F., Colicchio, & Perugi (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16382 · Cited by 45
Russell, A., Ciufolini, S., Gardner-Sood, P., Bonaccorso, S., Gaughran, F., Dazzan, P., Pariante, C. M., & Mondelli, V. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.004 · Cited by 44
Self-citationSzuster‐Ciesielska, A., Słotwińska, M., Stachura, A., Marmurowska-Michałowska, H., & Kandefer‐Szerszeń, M. (2004) · PubMed · Cited by 38
AChE and RACK1 Promote the Anti-Inflammatory Properties of Fluoxetine
Waiskopf, N., Ofek, K., Gilboa-Geffen, A., Bekenstein, U., Bahat, A., Bennett, E. R., Podoly, E., Livnah, O., Hartmann, G., & Soreq, H. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0174-6 · Cited by 34
Rudolf, S., Peters, M., Rothermundt, M., Arolt, V., & Kirchner, H. (2002) · Neuropsychobiology · doi:10.1159/000067807 · Cited by 34
Bleeker, M. W. P., Netea, M. G., Kullberg, B. J., van der Ven‐Jongekrijg, J., & van der Meer, J. W. M. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00285.x · Cited by 33
IFN-γ Reduction by Tricyclic Antidepressants
Himmerich, H., Fulda, S., Sheldrick, A. J., Plümäkers, B., & Rink, L. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.4.e · Cited by 29
Krause, D., Weidinger, E., Dippel, C., Riedel, M. J., Schwarz, M., Müller, N., & Myint, A.-M. (2013) · PubMed · Cited by 26
Chen, Z.-J., Vetter, M., Chang, G.-D., Liu, S., & Chang, C.-H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702685 · Cited by 25
Lu, R. (2012) · InTech eBooks · doi:10.5772/2268 · Cited by 25
Numao, S., Sasai, H., Nomata, Y., Matsuo, T., Eto, M., Tsujimoto, T., & Tanaka, K. (2012) · Obesity Facts · doi:10.1159/000346205 · Cited by 23
Effects of Antidepressants on IP-10 Production in LPS-Activated THP-1 Human Monocytes
Tsai, J., Kuo, C., Yang, P., Cheng, K., Wang, P., Chen, C., & Hung, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813223 · Cited by 21
Kubera, M., Kenis, G., Budziszewska, B., Bosmans, E., Scharpé, S., Basta‐Kaim, A., & Maes, M. H. J. (2001) · PubMed · Cited by 9
Suppressive effect of TRH and antidepressants on human interferon-γ productionin vitro
Kubera, M., Kenis, G., Basta‐Kaim, A., Bosmans, E., Budziszewska, B., Scharpe, S., & Maes, M. H. J. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140505.x · Cited by 2
Cited by
Wang, A. K., & Miller, B. J. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx035 · Cited by 389
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285
“Moreover, long-term L-DOPA therapy or antidepressant therapy often administered to patients in late disease stage, may affect immune responses in opposite directions, adding a factor of complication to human studies (Barnum et al., 2008; Baumeister et al., 2015; Lindqvist et al., 2013).”
BackgroundBrain microglia in psychiatric disorders
Mondelli, V., Vernon, A. C., Turkheimer, F., Dazzan, P., & Pariante, C. M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30101-3 · Cited by 265
Self-citation
Metadata
- Authors
- Baumeister, D., Ciufolini, S., & Mondelli, V.
- Affiliations
- King's College London (GB)
- Corresponding author
- Mondelli, Valeria
- Venue
- Psychopharmacology
- Published
- 2015-08-14
- Volume
- 233
- Issue
- 9
- Pages
- 1575-1589
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1763837731
- Semantic Scholar
- b2503d4446217bbaf3c2294d77587cfafb55e8d7
- Cited by
- 183
- References
- 108
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 14 · 2023: 14 · 2022: 23 · 2021: 26 · 2020: 15 · 2019: 22 · 2018: 19 · 2017: 17 · 2016: 11 · 2015: 3
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (CL-2008-17-005)
- Academy of Medical Sciences (AMS-SGCL5-Mondelli)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- psychotropic drugs, inflammation, immune system, antidepressants, antipsychotic drugs, inflammatory cytokines, interleukin-6, TNF-α, interferon-gamma, depression, psychosis, treatment response, personalized treatment, clomipramine, fluoxetine, mirtazapine, venlafaxine, haloperidol, clozapine, risperidone
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Immunologic Factors, Inflammation, Psychiatry, Psychotropic Drugs, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.